Avecho Biotechnology Limited AVE.AX Stock
Avecho Biotechnology Limited Price Chart
Avecho Biotechnology Limited AVE.AX Financial and Trading Overview
| Avecho Biotechnology Limited stock price | 0.0040 AUD |
| Previous Close | 0.006 AUD |
| Open | 0.006 AUD |
| Bid | 0.005 AUD x N/A |
| Ask | 0.006 AUD x N/A |
| Day's Range | 0.006 - 0.006 AUD |
| 52 Week Range | 0.004 - 0.02 AUD |
| Volume | 12.23M AUD |
| Avg. Volume | 2.85M AUD |
| Market Cap | 12.97M AUD |
| Beta (5Y Monthly) | 1.65977 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 19, 1997 |
| 1y Target Est | 1.72 AUD |
AVE.AX Valuation Measures
| Enterprise Value | 11.64M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.48802 |
| Price/Book (mrq) | 6 |
| Enterprise Value/Revenue | 10.31 |
| Enterprise Value/EBITDA | -5.529 |
Trading Information
Avecho Biotechnology Limited Stock Price History
| Beta (5Y Monthly) | 1.65977 |
| 52-Week Change | -50.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 AUD |
| 52 Week Low | 0.004 AUD |
| 50-Day Moving Average | 0.00509 AUD |
| 200-Day Moving Average | 0.0093525 AUD |
AVE.AX Share Statistics
| Avg. Volume (3 month) | 2.85M AUD |
| Avg. Daily Volume (10-Days) | 2.08M AUD |
| Shares Outstanding | 2.16B |
| Float | 1.08B |
| Short Ratio | N/A |
| % Held by Insiders | 17.56% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1.27:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -207.42% |
| Operating Margin (ttm) | -206.86% |
| Gross Margin | 70.23% |
| EBITDA Margin | -186.46% |
Management Effectiveness
| Return on Assets (ttm) | -33.98% |
| Return on Equity (ttm) | -67.29% |
Income Statement
| Revenue (ttm) | 1.13M AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | -29.69% |
| Gross Profit (ttm) | 793.12K AUD |
| EBITDA | -2105691 AUD |
| Net Income Avi to Common (ttm) | -2342391 AUD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.47M AUD |
| Total Cash Per Share (mrq) | 0.001 AUD |
| Total Debt (mrq) | 246.08K AUD |
| Total Debt/Equity (mrq) | 10.15 AUD |
| Current Ratio (mrq) | 3.825 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1665207 AUD |
| Levered Free Cash Flow (ttm) | -864372 AUD |
Profile of Avecho Biotechnology Limited
| Country | Australia |
| State | VIC |
| City | Clayton |
| Address | 2A Westall Road |
| ZIP | 3168 |
| Phone | 61 3 9002 5000 |
| Website | https://avecho.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health related products using its proprietary drug delivery system, Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Q&A For Avecho Biotechnology Limited Stock
What is a current AVE.AX stock price?
Avecho Biotechnology Limited AVE.AX stock price today per share is 0.0040 AUD.
How to purchase Avecho Biotechnology Limited stock?
You can buy AVE.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avecho Biotechnology Limited?
The stock symbol or ticker of Avecho Biotechnology Limited is AVE.AX.
Which industry does the Avecho Biotechnology Limited company belong to?
The Avecho Biotechnology Limited industry is Biotechnology.
How many shares does Avecho Biotechnology Limited have in circulation?
The max supply of Avecho Biotechnology Limited shares is 3.17B.
What is Avecho Biotechnology Limited Price to Earnings Ratio (PE Ratio)?
Avecho Biotechnology Limited PE Ratio is now.
What was Avecho Biotechnology Limited earnings per share over the trailing 12 months (TTM)?
Avecho Biotechnology Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Avecho Biotechnology Limited company belong to?
The Avecho Biotechnology Limited sector is Healthcare.